Tianjin Med J ›› 2016, Vol. 44 ›› Issue (1): 117-120.doi: 10.11958/58834
Previous Articles Next Articles
LIU Lu, DU Fangteng, WEN Yi, ZHANG Jixiang△
Received:
Revised:
Published:
Online:
Contact:
LIU Lu, DU Fangteng, WEN Yi, ZHANG Jixiang△. Research progress on RLRs in the treatment of multiple sclerosis[J]. Tianjin Med J, 2016, 44(1): 117-120.
Abstract: Abstract: At present, the etiology and pathogenesis of multiple sclerosis are unclear. RIG-Ⅰ-like receptors are a new⁃ ly discovered pattern recognition receptors (RLRs), which are located in cytoplasm. They can recognize the helicase of viral dsRNAs, and interact with interferon beta promoter stimulator (IPS)-1 through their caspase activation recruitment domain (CARD), then form IPS-1 signalsome and induce the expression of interferon type Ⅰ (Ⅰ-IFN), thereby initiate innate im⁃ mune response and induce antiviral response. Recent studies have found that mice lacking IPS-1 would develop exacerbated disease and accompanied by markedly higher inflammation, increasing axonal damage and demyelination. Furthermore, initi⁃ ating the RIG-Ⅰ-like helicase receptor on the immune cells can alleviate inflammation and myelin fracture in multiple scle⁃ rosis of mouse model, thus limit the incidence of paralysis. This paper is a review about the research progress on RLRs in the treatment of multiple sclerosis.
Key words: multiple sclerosis, interferon type Ⅰ, review, RIG-Ⅰ-like receptor, IPS
/ Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.tjyybjb.ac.cn/EN/10.11958/58834
https://www.tjyybjb.ac.cn/EN/Y2016/V44/I1/117